Overview

Metabolic Effects of Betaine Supplementation

Status:
Completed
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
Betaine is important in cellular metabolic pathways. Few epidemiologic studies link betaine levels to diabetes and cardiovascular disease. Small human studies suggest benefit for non-alcoholic liver disease. In this study we will determine if administration of betaine improves metabolic measures, liver fat and/or endothelial function in humans with glucose intolerance who are overweight.
Phase:
Phase 2
Details
Lead Sponsor:
Joslin Diabetes Center
Collaborator:
American Diabetes Association
Treatments:
Betaine
Glycine